Address
Email address
Phone number
https://globalaes.comAccelerated Enrollment Solutions for Patient Recruitment | AESAES helps biopharmaceutical and biotechnology companies overcome patient recruitment and research site challenges. Learn about our recruitment solutions.
Name
Center for Clinical and Basic Research AS
Registry code
10746218
VAT number
EE100684494
Type
AS - Joint Stock Company
Status
Registered
Foundation date
23.03.2001 (24)
Financial year
01.01-31.12
Capital
25 560.00 €
Activity
72191 - Other research and experimental development on natural sciences and engineering
-
-
-
-
-
-
-
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Annuse OÜ 12118238 | 100% - 25 560.00 EUR | - | - | Shareholder |
| Ivo Valter
| - | Board member | - | |
| Elisabeth Helena Valter
| - | - | - | Board member |
| Karl Vilhelm Valter
| - | - | - | Board member |
| Katrin Valter
| - | - | - | Chairman of the board |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q4 | 158 166.69 € | 40 365.91 € | 43 229.17 € | 16 |
| 2024 Q3 | 153 851.8 € | 40 057.52 € | 42 960.29 € | 16 |
| 2024 Q2 | 383 181.08 € | 41 746.04 € | 44 828.64 € | 16 |
| 2024 Q1 | 200 471.1 € | 41 820.65 € | 44 535.8 € | 15 |
| 2023 Q4 | 197 134.75 € | 39 452.78 € | 42 379.28 € | 15 |
| 2023 Q3 | 202 947.59 € | 41 121.97 € | 43 962.9 € | 14 |
| 2023 Q2 | 213 539.92 € | 36 957.8 € | 39 719.24 € | 14 |
| 2023 Q1 | 260 810 € | 40 567.49 € | 43 477.37 € | 16 |
| 2022 Q4 | 219 402.63 € | 37 233.96 € | 40 082.57 € | 18 |
| 2022 Q3 | 203 934.28 € | 37 866.9 € | 40 884.63 € | 18 |
| 2022 Q2 | 113 509.28 € | 33 620.81 € | 36 270.94 € | 17 |
| 2022 Q1 | 126 288.2 € | 35 444.13 € | 37 794.62 € | 19 |
| 2021 Q4 | 153 448.71 € | 43 250.9 € | 46 091.81 € | 17 |
| 2021 Q3 | 3 131.1 € | 831 657.86 € | 44 402.5 € | 17 |
| 2021 Q2 | 25 382.88 € | 42 536.21 € | 43 510.76 € | 19 |
| 2021 Q1 | 22 687.8 € | 46 275.67 € | 48 863.6 € | 18 |
| 2020 Q4 | 34 524.63 € | 50 086.9 € | 52 429.66 € | 17 |
| 2020 Q3 | 34 648.22 € | 47 163.1 € | 50 012.8 € | 17 |
| 2020 Q2 | 37 998.52 € | 37 877.57 € | 38 770.51 € | 17 |
| 2020 Q1 | 67 075.67 € | 51 256.54 € | 53 985.34 € | 18 |
